caseism

Medfield Pharmaceuticals Case Solution & Answer

Susan Johnson, founder and CEO of Medfield Pharmaceuticals, faces conflicting advice for the extended term of the patent for the company’s flagship product, Fleximat provided by the patent in two years. With only three other products in the range of drugs Medfield, one of which has just received approval from the Food and Drug Administration in the U.S., product portfolio of strategic management of the company is paramount. However, a recent offer of 750 million purchase of the company completely changed its orientation. With this offer, Johnson has a chance to leave the company on a good note. Before making its recommendation, Johnson must determine the value of the company, with careful consideration of existing and potential future products. But it is not just a financial decision, as employees of Johnson and Medfield generally believe that the company is dedicated to the work of the utmost importance. This case is designed to move, MBA, executive education and MBA public. Is taught as a core subject “Financial Management and Policy” at the Graduate School of Business Administration Darden.
by
Marc Lipson,
Jenny Mead,
Jared Harris
Source: Darden School of Business
13 pages.
Date Posted: November 14, 2011. Prod #: UV5632-PDF-ENG
Medfield Pharmaceutical Case Solution

Share This

LOOK FOR A FREE CASE STUDY SOLUTION

JUST REGISTER NOW AND GET 50% OFF ON EACH CASE STUDY